SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community rallies around the meme-based token on the Solana network. Community members are actively sharing the token's contract address and encouraging others to swap $SOL for $UPDOG on $JUP.X. The coin has been live for over a year and the community is constantly asking each other the age old question, 'What's UpDog?'

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Fueled by community enthusiasm and references to "UpDog" trending lists, Rage Guy is experiencing a surge in interest. The community is rallying behind the coin, emphasizing its strong community and encouraging others to join before a potential "blast off." Discussions highlight the potential for growth and the importance of community unity.

SuperCom Ltd. engages in the provision of traditional and digital identity solutions. It offers identification, tracking, and security products to government, private and public organization. It operates through the following divisions: e-Gov, Internet of Things (IoT), and Cyber Security. The e-Gov division provides solutions for traditional and biometrics enrollment, personalization, issuance and border control services. The IoT division products and services reliably identify, track, and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles, and monitored objects. The Cyber Security division is involved in the comprehensive solutions to protect the organization's sensitive data residing on servers, laptops, and detachable devices. The company was founded by Jack Hasan and Eli Rozen on July 4, 1988 and is headquartered in Tel Aviv, Israel.

SuperCom Ltd

SPCB is trending as investors discuss the potential impact of new contracts, particularly one in Germany, and speculate about a possible ICE contract win. Community members are debating valuation, revenue projections, and the company's growth prospects given its small float. Some traders are closely watching technical indicators and anticipating a breakout.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

Uranium Energy Corp is trending amid bullish sentiment surrounding nuclear energy and discussions of potential policy tailwinds. Community members are actively discussing entry points, price targets, and the company's potential to benefit from increased demand driven by AI and data centers. Some traders are also noting unusual options activity and technical patterns, while others debate the company's valuation and production capabilities relative to its peers.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending due to a mix of positive news and ongoing debates about its valuation and future potential. Recent advancements, like achieving its quantum performance milestone early, are fueling optimism, while discussions around share dilutions and comparisons to other tech sectors contribute to market volatility. The community is actively debating the impact of these factors on the stock's short-term and long-term prospects, with some anticipating a short squeeze and others expressing concern about overvaluation.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics is trending after releasing Phase 3 trial data for their skin drug, sonelokimab, which showed mixed results and a higher-than-expected placebo response in one study. While some view the data as disappointing, others speculate on a potential buyout and future gains, leading to active discussions about the drug's efficacy and market potential. The community is also closely watching for potential short squeezes and overnight trading activity.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending due to a recently announced $44 million private placement, sparking significant after-hours trading activity. The community is actively discussing the potential impact of the financing on the company's growth and balance sheet, while also considering the stock's tight float and potential for continued momentum.

abrdn ETF - abrdn Physical Platinum Shares ETF

PPLT is trending due to bullish sentiment and unusual options activity, with traders anticipating a potential breakout. Community members are actively discussing market manipulation, supply deficits, and platinum's historical undervaluation compared to gold. Some analysts suggest that a global hydrogen powerplant buildout will cause platinum to surge and that with the Fed cutting rates, it will explode along with gold and silver.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as the community discusses its potential for significant growth, especially given its privacy features and upcoming halving event. Some believe ZEC is undervalued and poised to outperform Bitcoin, while others highlight its importance in a world concerned about transaction privacy. The integration of Zashi wallet with Coinbase is also driving interest.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending as community members discuss Cigna adding Auvelity to its preferred drug list in 2026, potentially setting a precedent for other insurers. Sponsorship of educational events and analysis of prescription data are also fueling conversation. Despite some concerns regarding share sales and pipeline candidates, many remain optimistic about Axsome's growth trajectory and potential FDA approvals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Law Offices of Frank R. Cruz Announces Investigation of Complete Solaria Inc. (CSLR) f/k/a Freedom Acquisition I Corporation (FACT) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of Complete Solaria Inc. (CSLR) f/k/a Freedom Acquisition I Corporation (FACT) on Behalf of Investors The Law Offices of Frank R. Cruz...

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Complete Solaria Inc. (Complete Solaria or Company) (NASDAQ: CSLR) f/k/a Freedom Acquisition I...

Facet Biotech Corporation, a biotechnology company, engages in the identification and development of oncology drugs. Facet was formed through a spin-off of the biotechnology segment of PDL BioPharma, Inc., which was completed on December 18, 2008. It was subsequently acquired by [Abbott Labs](/organization/abbott-labs). The company is headquartered in Redwood City, California.  Its products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company is also developing Elotuzumab, a monoclonal antibody in Phase I/II clinical studies, which binds to a cell surface glycoprotein that is expressed on myeloma cells and normal human cells; PDL192, a monoclonal antibody in Phase I clinical study, which binds to the tumor necrosis factor-like weak inducer of apoptosis receptor; PDL241, a monoclonal antibody in the preclinical stage for immunologic diseases; and TRU-016, a small modular immunopharmaceutical protein therapeutic in Phase I clinical studies for the treatment of B-cell malignancies, such as chronic lymphocytic leukemia and non-Hodgkin's lymphoma, as well as autoimmune and inflammatory disease indications. It has collaboration agreements with Biogen Idec Inc.; Bristol-Myers Squibb Company; and Trubion Pharmaceuticals, Inc. Facet Biotech Corporation also has license agreements with Abbott Laboratories, Inc.; Actinium Pharmaceuticals, Inc.; Genentech, Inc.; Ophthotech Corporation; Progenics Pharmaceuticals, Inc.; and Seattle Genetics, Inc.

FACT
Freedom Acquisition I Corp - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FACT News

FACT Freedom Acquisition I Corp - Ordinary Shares - Class A